Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-01-18
2011-01-18
Olson, Eric S (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S217000, C540S225000
Reexamination Certificate
active
07871997
ABSTRACT:
This invention provides cephalosporin compounds and salts thereof. Such compounds are useful for preparing cross-linked glycopeptide-cephalosporin antibiotics.
REFERENCES:
patent: 4457928 (1984-07-01), Teraji et al.
patent: 4463000 (1984-07-01), Teraji et al.
patent: 4521413 (1985-06-01), Teraji et al.
patent: 4550102 (1985-10-01), Teraji et al.
patent: 4833134 (1989-05-01), Kishimoto et al.
patent: 5071979 (1991-12-01), Lattrell et al.
patent: 7067481 (2006-06-01), Fatheree et al.
patent: 7067482 (2006-06-01), Fatheree et al.
patent: 7279458 (2007-10-01), Fatheree et al.
patent: 7332471 (2008-02-01), Fatheree et al.
patent: 0098609 (1983-07-01), None
patent: WO 99/64049 (1999-12-01), None
Blumbach et al., “Synthesis and Structure-Activity Relationships in the Series of HR 810 Variation of the Aminothiazole Moiety”, Proc. Int Congr. Chemother., 13th, 4, pp. 99/13-99/16 (1983).
Yoshizawa et al., “New Broad-Spectrum Parenteral Cephalosporins Exhibiting Potent Activity Against Both Methicillin-ResistantStaphylococcus aureus(MRSA) andPseudomonas aeruginosa. Part 3: 7β-[2-(5-Amino-1,2,4-thiediazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins Bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3”, Bioorganic & Medicinal Chemistry, 12, pp. 4221-4231 (2004).
U.S. Appl. No. 09/457,926, filed Dec. 8, 1999, Not published, Christensen et al.
Aggen James B.
Chinn Jason P.
Fatheree Paul R.
Linsell Martin S.
Long Daniel D.
Hagenah Jeffrey A.
Olson Eric S
Theravance Inc.
LandOfFree
Cephalosporin compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cephalosporin compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cephalosporin compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2677720